Community consensus on Reddit and published compounding pharmacy standards generally expect greater than 98% purity by HPLC for injectable-grade peptides
At Alloy, we start there by pairing menopause-informed care with physician-guided GLP-1 treatment, personalized dosing, and longitudinal support so weight is treated as part of a broader metabolic and hormonal picture. When women in menopause see weight gain, it is often accompanied by insulin resistance, changes to lipid profiles and more inflammation systemically
The present invention relates in a further aspect to a method for isolating a GLP-1 peptide, the method including purification of a GLP-1 peptide from a mixture comprising said peptide and related or unrelated impurities via a cation exchange chromatography process, the cation exchange chromatography process comprising the step of: separating said GLP-1 peptide and said related impurities of said mixture by elution in a solution consisting essentially of an organic modifier, water, optionally a salt component, and optionally a buffer, with a linear or step gradient or isocratically in salt component and/or with a linear or step pH-gradient or at a constant pH-value, wherein the pH-gradient or pH-value should be in the range where said peptide has a positive local or overall net charge different from the local or overall positive net charge of said related impurities so as to remove said related impurities
Trim Biome GLP-1 enhances GLP-1 injections by supercharging their effectiveness and improving gut health
Protection of schisantherin A against dictamnine-induced hepatotoxicity: pharmacokinetic insights
